Literature DB >> 18471644

Microbial cultures of the microkeratome blade immediately after flap construction in laser in situ keratomileusis.

Ahsan M Khan1, Bruce Larson, James Noth, Roger Rosen, Charles Bouchard.   

Abstract

PURPOSE: To assess the incidence of positive cultures from samples of the microkeratome blade after routine laser in situ keratomileusis (LASIK) procedures as a measure of the risk for postoperative infectious keratitis.
SETTING: Hinsdale Surgical Center, Hinsdale, Illinois, USA.
METHODS: In this prospective study, 99 microkeratome blades (Hansatome) were cultured after routine LASIK procedures by multiple surgeons at an ambulatory surgery center. Cultures were sent for routine aerobic and anaerobic growth. Positive cultures were then sent for routine sensitivities.
RESULTS: Five of 99 swabs of microkeratome blades were culture positive. Four cultures grew Staphylococcus epidermidis and 1, Staphylococcus warneri. Two of the staphylococcal cultures were resistant to ciprofloxacin and levofloxacin but sensitive to moxifloxacin and gatifloxacin.
CONCLUSIONS: The study demonstrated a 5% positive culture rate from the microkeratome blade after routine LASIK surgery by multiple surgeons in an ambulatory surgery center. No patient with positive cultures developed postoperative infectious keratitis. Factors other than the presence of bacteria contribute to the development of clinical infection.

Entities:  

Mesh:

Year:  2008        PMID: 18471644     DOI: 10.1016/j.jcrs.2008.01.025

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  2 in total

1.  A rare devastating complication of LASIK: bilateral fungal keratitis.

Authors:  H Taylan Sekeroglu; E Erdem; K Yar; M Yağmur; T R Ersoz; A Uguz
Journal:  J Ophthalmol       Date:  2010-11-11       Impact factor: 1.909

2.  Clinical diagnosis and treatment of rare painless keratitis caused by three pathogens: clinical practice and experiential discussion.

Authors:  Yiming Sun; Wenjing Li; MiMi Wang; Quansheng Xing; Xuguang Sun
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.